z-logo
Premium
Evidence for Distinct 5‐Hydroxytryptamine 2 Binding Site Subtypes in Cortical Membrane Preparations
Author(s) -
Pierce Pamela A.,
Peroutka Stephen J.
Publication year - 1989
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.1989.tb09171.x
Subject(s) - ketanserin , binding site , population , cortex (anatomy) , cerebral cortex , biology , serotonin , receptor , 5 ht receptor , microbiology and biotechnology , chemistry , biophysics , endocrinology , biochemistry , neuroscience , medicine , environmental health
5‐Hydroxytryptamine (5‐HT) displays a sixfold higher affinity for 5‐HT 2 binding sites labeled by [ 3 H]ketanserin in rat (IC 50 = 200 ± 40 n M ) and human (IC 50 = 190 ± 50 n M ) cortex than for 5‐HT 2 sites in bovine cortex (IC 50 = 1,200 ± 130 n M ). The Hill slopes of the 5‐HT competition curves are 0.67 ± 0.04 in rat, 0.69 ± 0.08 in human, and 0.96 ± 0.02 in bovine cortex. Scatchard analysis of (±)‐( 3 H]4‐bromo‐2,5‐dimethoxyamphetamine ([ 3 H]DOB) binding in the rat indicates a population of binding sites with a K D of 0.38 ± 0.04 n M and a B max of 1.5 ± 0.05 pmol/g tissue. In contrast, specific [ 3 H]DOB binding cannot be detected in bovine cortical membranes. These data indicate that species variations exist in 5‐HT 2 binding site subtypes and that [ 3 H]ketanserin appears to label a homogeneous population of 5‐HT 2 binding site subtypes in bovine cortex.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom